Details

Autor(en) / Beteiligte

• Généreux, Philippe
• Sharma, Rahul P.
• Cubeddu, Robert J.
• Aaron, Lucy
• Abdelfattah, Omar M.
• Koulogiannis, Konstantinos P.
• Marcoff, Leo
• Naguib, Mostafa
• Kapadia, Samir R.
• Makkar, Rajendra R.
• Thourani, Vinod H.
• van Boxtel, Benjamin S.
• Cohen, David J.
• Dobbles, Michael
• Barnhart, Glenn R.
• Kwon, Michelle
• Pibarot, Philippe
• Leon, Martin B.
• Gillam, Linda D.

Titel

The Mortality Burden of Untreated Aortic Stenosis

Ist Teil von

• Journal of the American College of Cardiology, 2023-11, Vol.82 (22), p.2101-2109

Ort / Verlag

United States: Elsevier Inc

Erscheinungsjahr

2023

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• The American College of Cardiology/American Heart Association guidelines recommend the assessment and grading of severity of aortic stenosis (AS) as mild, moderate, or severe, per echocardiogram, and recommend aortic valve replacement (AVR) when the AS is severe. The authors sought to describe mortality rates across the entire spectrum of untreated AS from a contemporary, large, real-world database. We analyzed a deidentified real-world data set including 1,669,536 echocardiographic reports (1,085,850 patients) from 24 U.S. hospitals (egnite Database, egnite). Patients >18 years of age were classified by diagnosed AS severity. Untreated mortality and treatment rates were examined with Kaplan-Meier (KM) estimates, with results compared using the log-rank test. Multivariate hazards analysis was performed to assess associations with all-cause mortality. Among 595,120 patients with available AS severity assessment, the KM-estimated 4-year unadjusted, untreated, all-cause mortality associated with AS diagnosis of none, mild, mild-to-moderate, moderate, moderate-to-severe, or severe was 13.5% (95% CI: 13.3%-13.7%), 25.0% (95% CI: 23.8%-26.1%), 29.7% (95% CI: 26.8%-32.5%), 33.5% (95% CI: 31.0%-35.8%), 45.7% (95% CI: 37.4%-52.8%), and 44.9% (95% CI: 39.9%-49.6%), respectively. Results were similar when adjusted for informative censoring caused by treatment. KM-estimated 4-year observed treatment rates were 0.2% (95% CI: 0.2%-0.2%), 1.0% (95% CI: 0.7%-1.3%), 4.2% (95% CI: 2.0%-6.3%), 11.4% (95% CI: 9.5%-13.3%), 36.7% (95% CI: 31.8%-41.2%), and 60.7% (95% CI: 58.0%-63.3%), respectively. After adjustment, all degrees of AS severity were associated with increased mortality. Patients with AS have high mortality risk across all levels of untreated AS severity. Aortic valve replacement rates remain low for patients with severe AS, suggesting that more research is needed to understand barriers to diagnosis and appropriate approach and timing for aortic valve replacement. [Display omitted]